Aarey Drugs

36
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
84.92
4.04 (5.0%)
BSENSE

Aug 27, 02:30 PM

BSE+NSE Vol: 2.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024

Compare Profit and Loss Results of Aarey Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
72.00
401.00
556.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
473.00
72.00
401.00
556.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
0.00
-10.00
0%
Raw Materials Consumed
472.00
21.00
451.00
2,147.62%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
35.00
-35.00
-100.00%
Operating Expenses
1.00
2.00
-1.00
-50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
13.00
-10.00
-76.92%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
471.00
85.00
386.00
454.12%
Operating Profit (PBDIT) excl Other Income
2.00
-12.00
14.00
116.67%
Other Income
9.00
5.00
4.00
80.00%
Operating Profit (PBDIT)
12.00
-7.00
19.00
271.43%
Interest
4.00
3.00
1.00
33.33%
Profit before Depriciation and Tax
8.00
-11.00
19.00
172.73%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
6.00
-13.00
19.00
146.15%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-13.00
19.00
146.15%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
4.00
-13.00
17.00
130.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
53.00
-8.00
61.00
762.50%
Profit Available for appropriations
57.00
-22.00
79.00
359.09%
Appropriations
57.00
-22.00
79.00
359.09%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.42
-11.45
12.87
112.40%
Profit And Loss - Net Sales
Net Sales 473.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024

Profit And Loss - Interest
Interest 4.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024